COMMITTEE TO HOLD HEARING WITH ABBVIE CEO AND EXPERTS ON PRICING PRACTICES FOR HUMIRA AND IMBRUVICA MAY

Source :: States News Service. May 14, 2021
Publication Year :: 2021
Abstract: WASHINGTON, DC -- The following information was released by the U.S. House of Representatives Committee on Oversight and Government Reform: On Tuesday, May 18, 2021, at 10:00 a.m., Rep. Carolyn [...]

Subjects :: AbbVie Inc. -- Political activity -- Prices and rates
Chief executive officers -- Political aspects -- Political activity
Drugs -- Prices and rates
Chairpersons -- Political activity -- Political aspects
Pharmaceutical industry -- Prices and rates -- Political aspects -- Political activity
Company pricing policy
News, opinion and commentary
Imbruvica (Medication) -- Prices and rates
Humira (Medication) -- Prices and rates

Tools